Antibody-based therapy discovered at The Lundquist Institute is several steps closer to treating a lethal fungal infection
The Lundquist Institute holds both U.S. and international patents for this humanized antibody and has granted Vitalex, a Lundquist spin-off company, the commercial rights to advance this therapeutic ...
Antibody-based therapy is several steps closer to treat lethal mucormycosis
Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and ...